Search Within

Niloufer Khan

Formats
  1. Meeting Abstract (28)
  2. Journal Article (15)
  3. Editorial (2)
  4. Correspondence (1)
  5. Miscellaneous (1)
  6. Review (1)
Groups
  1. Hematologic Malignancies, Division of (48)
  2. Survivorship Research (48)
  3. Department of Medicine (44)
  4. Center for Hematologic Malignancies (41)
  5. Lymphoma (34)
  6. Population Sciences Research Program (32)

More Groups

People
  1. Steven Horwitz (28)
  2. Alison Moskowitz (26)
  3. Andrew Zelenetz (17)
  4. Matthew Matasar (17)
  5. Anita Kumar (15)
  6. Ariela Noy (15)

More People

Years
  1. 2023 (5)
  2. 2022 (12)
  3. 2021 (13)
  4. 2020 (4)
  5. 2019 (7)
  6. 2018 (6)

More Years

Publications
  1. Blood (20)
  2. Journal of Clinical Oncology (4)
  3. Hematological Oncology (3)
  4. Leukemia and Lymphoma (3)
  5. Biology of Blood and Marrow Transplantation (2)
  6. Blood Advances (2)

More Publications

Publishers
  1. American Society of Hematology (22)
  2. Elsevier Inc. (5)
  3. American Society of Clinical Oncology (4)
  4. Taylor & Francis Group (4)
  5. Wiley Blackwell (3)
  6. Springer (1)

More Publishers

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunotherapy in mycosis fungoides: Opening night or dress rehearsal?
    Editorial

    Khan, N.; Horwitz, S.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Multicenter microbiota analysis indicates that pre-HCT microbiota injury is prevalent across geography and predicts poor overall survival
    Meeting Abstract

    Peled, J. U.; Gomes, A. L. C.; Stein-Thoeringer, C. K.; Slingerland, J. B.; Slingerland, A. E.; Weber, D.; Markey, K. A.; Smith, M.; Ponce, D.; Clurman, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Loss of microbiota diversity after autologous stem cell transplant is comparable to injury in allogeneic stem cell transplant
    Meeting Abstract

    Khan, N.; Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Rondon-Clavo, C.; Clurman, A.; Slingerland, J. B.; Slingerland, A. E.; Maloy, M.; Sung, A. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Role of single agent and combination chemotherapy strategies in relapsed/refractory peripheral T-cell lymphoma: Results from the complete registry
    Meeting Abstract

    Stuver, R.; Khan, N.; Schwartz, M.; Acosta, M.; Federico, M.; Gisselbrecht, C.; Lansigan, F.; Pinter-Brown, L. C.; Pro, B.; Shustov, A. R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in the United States
    Meeting Abstract

    Feliciano, J.; Mueller, K.; Korol, E. E.; He, Z.; Khan, N.; Matasar, M. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Peripheral T-cell lymphoma – Are we making progress?
    Journal Article

    Khan, N.; Ozkaya, N.; Moskowitz, A.; Dogan, A.; Horwitz, S.
    Best Practice and Research: Clinical Haematology (2018)

    Fulltext@MSK | Save
  • Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: Systematic review and meta-analysis
    Journal Article

    Baxi, S.; Yang, A.; Gennarelli, R. L.; Khan, N.; Wang, Z.; Boyce, L.; Korenstein, D.
    BMJ: British Medical Journal (International Edition) (2018)

    Fulltext@MSK | Save
  • Where do the new drugs fit in for relapsed/refractory Hodgkin lymphoma?
    Journal Article

    Khan, N.; Moskowitz, A. J.
    Current Hematologic Malignancy Reports (2017)

    Fulltext@MSK | Save